Genetically modified salmon moved closer to the market last week with release of draft documents from the Food and Drug Administration that assessed the environmental risks posed by AquAdvantage salmon, which grow faster than regular Atlantic salmon.
The agency found, on a preliminary basis, that the GM fish, produced by AquaBounty Technologies of Massachusetts, posed no significant threat.
LINK (LA Times)